Behavioral
Park Center INC
Park Center INC was paid $26.68M by Medicaid between Jan 2018 and Dec 2024, across 41 billing codes. Its largest line is H0010, Alcohol and/or drug services; sub-acute detoxification (residential addiction program inpatient) — 45% of everything it billed.
33Billing provider infoPARK CENTER INC
FORT WAYNE, IN 46805
FORT WAYNE, IN 46805
33aNPI1306897004assigned 05/15/2006
33bProvider typeAddiction (Substance Use Disorder) Psychologist
28Total paid$26.68M
24GClaims407,206
24DCodes billed41
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 47,856 | $1.24M | |
| 2019 | 48,798 | $2.35M | |
| 2020 | 47,034 | $3.57M | |
| 2021 | 55,895 | $3.65M | |
| 2022 | 69,676 | $5.73M | |
| 2023 | 87,955 | $6.71M | |
| 2024incomplete | 49,992 | $3.44M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| H0010 | Alcohol and/or drug services; sub-acute detoxification (residential addiction program inpatient) | 45% | 42,296 | 2,866 | $11.93M |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 16% | 96,667 | 54,423 | $4.26M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 77,056 | 66,600 | $4.20M |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | 5.7% | 20,911 | 18,402 | $1.53M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.2% | 25,171 | 22,704 | $865K |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | 2.6% | 9,305 | 6,426 | $684K |
| 90792 | Psychiatric diagnostic evaluation with medical services | 2.3% | 7,057 | 6,322 | $610K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 2.0% | 37,980 | 15,713 | $524K |
| 90847 | Family psychotherapy with the patient present, 50 minutes | 1.8% | 8,577 | 5,967 | $471K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 1.7% | 13,855 | 10,037 | $458K |
| 90839 | <1% | 3,022 | 2,714 | $195K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 22,005 | 17,655 | $174K |
29 more codes
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 6,471 | $161K |
| 99223 | Prolong inpt eval add15 m | <1% | 853 | $85K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 821 | $76K |
| H2034 | Alcohol and/or drug abuse halfway house services, per diem | <1% | 1,602 | $67K |
| 80305 | <1% | 14,392 | $65K | |
| H2011 | Crisis intervention service, per 15 minutes | <1% | 198 | $59K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 1,730 | $45K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 725 | $30K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 507 | $30K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,758 | $23K |
| J2426 | Injection, paliperidone palmitate extended release (invega sustenna), 1 mg | <1% | 3,664 | $23K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 446 | $19K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 596 | $18K |
| 99205 | Prolong outpt/office vis | <1% | 235 | $16K |
| 96127 | <1% | 3,356 | $14K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 811 | $13K |
| J2315 | Injection, naltrexone, depot form, 1 mg | <1% | 942 | $13K |
| 81025 | <1% | 1,383 | $9K | |
| 90846 | Family psychotherapy without the patient present, 50 minutes | <1% | 138 | $8K |
| 99221 | <1% | 176 | $7K | |
| J0401 | Injection, aripiprazole (abilify maintena), 1 mg | <1% | 1,214 | $809.69 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 119 | $802.95 |
| 99201 | <1% | 62 | $800.57 | |
| 82075 | <1% | 179 | $493.15 | |
| 86580 | <1% | 75 | $448.05 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 53 | $217.20 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 754 | $1.69 |
| Q9992 | Injection, buprenorphine extended-release (sublocade), greater than 100 mg | <1% | 28 | $0.14 |
| T2011 | Preadmission screening and resident review (pasrr) level ii evaluation, per evaluation | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBIGELOW, KRIS (DIRECTOR ENTERPRISE CREDENTIALING &)